Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancer-Reference-Cited by-同舟云学术

Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancer

Published:2020-02-18 Issue:2 Volume:15 Page:e0229077
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Nair Sindhu^ORCID,Trummell Hoa Q.^ORCID,Rajbhandari Rajani,Thudi Nanda K.,Nozell Susan E.,Warram Jason M.,Willey Christopher D.^ORCID,Yang Eddy S.,Placzek William J.^ORCID,Bonner James A.^ORCID,Bredel Markus^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference58 articles.

1. Comprehensive genomic characterization of head and neck squamous cell carcinomas;Cancer Genome Atlas N.;Nature,2015

2. The molecular landscape of head and neck cancer;CR Leemans;Nat Rev Cancer,2018

3. The mutational landscape of head and neck squamous cell carcinoma;N Stransky;Science,2011

5. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck;JA Bonner;N Engl J Med,2006

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Agonistic Activity of the Human Epidermal Growth Factor is Reduced by the D46G Substitution;Protein & Peptide Letters;2024-07

2. Overcoming Resistance to Standard-of-Care Therapies for Head and Neck Squamous Cell Carcinomas;Cells;2024-06-11

3. Cetuximab chemotherapy resistance: Insight into the homeostatic evolution of head and neck cancer (Review);Oncology Reports;2024-04-19

4. Computational Characterization of Membrane Proteins as Anticancer Targets: Current Challenges and Opportunities;International Journal of Molecular Sciences;2024-03-26

5. Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinoma;Frontiers in Medicine;2023-02-02